Outcomes After Intravenous Alteplase / Tenecteplase With or Without Shuxuetong Injection in Routine Clinical Practice
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT06018181 |
|
Recruitment Status :
Not yet recruiting
First Posted : August 30, 2023
Last Update Posted : August 30, 2023
|
Sponsor:
Dongzhimen Hospital, Beijing
Information provided by (Responsible Party):
Ying Gao, Dongzhimen Hospital, Beijing
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Not yet recruiting |
|---|---|
| Estimated Primary Completion Date : | April 30, 2025 |
| Estimated Study Completion Date : | December 31, 2025 |